1-6 of 6
Jennifer A. Kanakry, MD
Close
Sort by
Journal Articles

Low Levels of Neurologic Toxicity with Retained Anti-Lymphoma Activity in a Phase I Clinical Trial of T Cells Expressing a Novel Anti-CD19 CAR

Jennifer Brudno, MD, Steven Hartman, Norris Lam, BS, David F. Stroncek, John M. Rossi, MS, Yueh-wei Shen, Allen Xue, PhD, Adrian Bot, MD PhD, Jennifer A Kanakry, MD, Steven Z. Pavletic, MD, Lekha Mikkilineni, MD, Mark Roschewski, MD, Robert M. Dean, MD, Jeremy J. Rose, MS, Rashmika Patel, Brenna Hansen, Steve A. Rosenberg, Ronald E. Gress, MD, James N. Kochenderfer, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 697.
https://doi.org/10.1182/blood-2018-99-113731
Published: 2018
Journal Articles

Regression of Epithelial Cancers Following T Cell Receptor Gene Therapy Targeting Human Papillomavirus-16 E7

Scott Michael Norberg, DO, Nisha Nagarsheth, PhD, Stacey Doran, MD, Jennifer A Kanakry, MD, Sabina Adhikary, PhD, Colleen Schweitzer, PhD, Stephanie H Astrow, PhD, William Faquin, MD, Nikolaos Gkitsas, Steven Highfill, PhD, Christian S Hinrichs
Journal: Blood
Blood (2018) 132 (Supplement 1): 492.
https://doi.org/10.1182/blood-2018-99-117017
Published: 2018
Journal Articles

T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor with a CD28 Costimulatory Moiety Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

Jennifer Brudno, MD, Norris Lam, BS, Michael Wang, MD, David Stroncek, MD, Irina Maric, Maryalice Stetler-Stevenson, Constance Yuan, Steven Hartman, Jennifer A. Kanakry, MD, Steven Z. Pavletic, MD, Steven A. Feldman, Judith Lawrence, Rashmika Patel, Brenna Hansen, Ronald E. Gress, MD, James N. Kochenderfer, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 524.
https://doi.org/10.1182/blood.V130.Suppl_1.524.524
Published: 2017
Journal Articles

Gray Zone Lymphoma (GZL) with Features Intermediate between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): A Pathologic Consensus Study with Patient Outcomes and Prognostication across 15 North American Centers

Andrew M Evens, DO,MSc, Monika Pilichowska, MD PhD, Stefania Pittaluga, MD PhD, Judith Ferry, MD, Jessica Hemminger, MD, Hong Chang, PhD, Jennifer A. Kanakry, MD, Laurie H Sehn, Tatyana A Feldman, MD, Francisco J. Hernandez-Ilizaliturri, MD, Izidore S Lossos, MD, Jeremy S. Abramson, MD, Athena Kritharis, MD, Oliver W. Press, MD PhD, Timothy S. Fenske, MD, Jonathan W. Friedberg, MD, Julie M Vose, MD, Kristie A. Blum, MD, Deepa Jagadeesh, MDMPH, Bruce Woda, MD, Randy D. Gascoyne, MD, Elaine S. Jaffe, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 375.
https://doi.org/10.1182/blood.V130.Suppl_1.375.375
Published: 2017
Journal Articles

T Cells Expressing a Novel Fully-Human Anti-CD19 Chimeric Antigen Receptor Induce Remissions of Advanced Lymphoma in a First-in-Humans Clinical Trial

Jennifer N. Brudno, MD, Victoria Shi, David Stroncek, MD, Stefania Pittaluga, MD PhD, Jennifer A. Kanakry, MD, Lauren M. Curtis, MD, Juan C. Gea-Banacloche, MD, Steven Pavletic, MD, Mohammad-Hadi Bagheri, MD, Jeremy J. Rose, MS, Rashmika Patel, Brenna Hansen, Ronald E. Gress, MD, James N. Kochenderfer, MD
Journal: Blood
Blood (2016) 128 (22): 999.
https://doi.org/10.1182/blood.V128.22.999.999
Published: 2016
Journal Articles

Serum Biomarkers Predict Outcomes in Advanced Hodgkin Lymphoma Independent of International Prognostic Score (IPS) and Treatment: Correlative Analysis from a Large North American Cooperative Group Trial

Jennifer A. Kanakry, MD, Fangxin Hong, PhD, Otoniel Martinez-Maza, PhD, Sandra J Horning, MD, Leo I. Gordon, MD, Randy D Gascoyne, MD, Lan L Gellert, MD PhD, M. Victor Lemas, Bruce Cheson, MD, Ranjana H Advani, MD, Brad Pohlman, MD, Vaishalee P. Kenkre, MD, Jane N. Winter, MD, Patrick J. Stiff, MD, Joseph Tuscano, MD, Jonathan Friedberg, MD, Lydia Dreosti, MBBCH, FCP(SA), Richard I. Fisher, MD, Pierre Laneuville, MD FRCPC, Brad S Kahl, Richard F. Ambinder, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2992.
https://doi.org/10.1182/blood.V128.22.2992.2992
Published: 2016